Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward

Abstract

Get full access to this article

View all access options for this article.

References

State Marijuana Laws in. 2018. map. 2018. Available at www.governing.com/gov-data/safety-justice/state-marijuana-laws-map-medical-recreational.html (last accessed February 13, 2019).

Bill C-45, the Cannabis Act, Passed in Senate. 2018. Available at https://www.canada.ca/en/health-canada/news/2018/06/bill-c-45-the-cannabis-act-passed-in-senate.html (last accessed February 13, 2019).

Marijuana use and pregnancy. 2018. Available at https://www.cdc.gov/marijuana/factsheets/pregnancy.htm (last accessed February 13, 2019).

Legal weed market to triple in 5 years. 2017. Available at https://www.investopedia.com/news/legal-weed-market-triple-5-years (last accessed February 13, 2019).

The National Academy of Sciences, Engineering and Medicine. The health effects of cannabis and cannabinoids. The National Academy Press: Washington, DC, 2017, p. 382.

The University of California performs nearly one-tenth of all the academic research and development conducted in the United States. 2018. Available at https://accountability.universityofcalifornia.edu/2018/chapters/chapter-9.html#9.1.4 (last accessed February 13, 2019).

Hillig

. Genetic evidence for speciation in Cannabis (Cannabaceae). Genet Resour Crop Evol, 2005; 52:16–1.

Clarke

, Merlin

. Cannabis: evolution and ethnobotany. University of California Press: Berkeley, CA, 2015.

ElSohly

, Radwan

, Gul

, et al. Phytochemistry of Cannabis sativa L. In: Kinghorn

, Falk

, Gibbons

et al., (eds.), Phytocannabinoids, progress in the chemistry of organic natural products 103, Springer: Cham, Switzerland, 2017, pp. 1–30.

10.

Long

, Wagner Demske

, et al. Cannabis in Eurasia: origin of human use and Bronze Age trans-continental connections. Veget Hist Archaeobot. 2016; 26: 245–258.

11.

McPartland

, Guy

, Hegman

. Cannabis is indigenous to Europe and cultivation began during the Copper or Bronze age: a probabilistic synthesis of fossil pollen studies. Veget Hist Archaeobot. 2018; 27:63–5.

12.

Russo

. Cannabidiol: claims and misconceptions. Trends Pharmacol Sci. 2017; 38:198–201.

13.

Turner

, Williams

, Iversen

, et al. Molecular pharmacology of phytocannabinoids. In: Kinghorn

, Falk

, Gibbons

et al., (eds.), Phytocannabinoids, progress in the chemistry of organic natural products 103, Springer: Cham, Switzerland, 2017, pp. 61–99.

14.

Devane

, Dysarz FA 3rd, Johnson

, et al. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34:605–613.

15.

Matsuda

, Lolait

, Brownstein

, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346:561–564.

16.

Herkenham

, Lynn

, Little

, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A. 1990; 87:1932–1936.

17.

Rinaldi-Carmona

, Barth

, Héaulme

, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994; 350:240–244.

18.

Devane

, Hanus

, Breuer

, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992; 258:1946–1949.

19.

Di Marzo

, Fontana

. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994; 372:686–691.

20.

Mechoulam

, Ben-Shabat

, Hanus

, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995; 50:83–90.

21.

Stella

, Schweitzer

, Piomelli

. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 1997; 388:773–778.

22.

Title 21 United States Code (USC) Controlled Substances Act. 2016. Available at https://www.deadiversion.usdoj.gov/21cfr/21usc (last accessed February 13, 2019).

23.

United States Drug Enforcement Administration. Drug scheduling. Available at https://www.dea.gov/drug-scheduling (last accessed February 13, 2019).

24.

Subchapter I—Control and enforcement. 2016. Available at https://www.deadiversion.usdoj.gov/21cfr/21usc/802.htm (last accessed February 13, 2019).

25.

FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. 2018. Available at https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611046.htm (last accessed February 13, 2019).

26.

FDA-approved drug epidiolex placed in Schedule V of Controlled Substance Act. 2018. Available at https://www.dea.gov/press-releases/2018/09/27/fda-approved-drug-epidiolex-placed-schedule-v-controlled-substance-act (last accessed February 13, 2019).

27.

S.2667–Hemp Farming Act of. 2018. 2018. Available at https://www.congress.gov/bill/115th-congress/senate-bill/2667 (last accessed February 13, 2019).

28.

IFAP. Part 86—drug-free schools and campuses. Available at https://ifap.ed.gov/regcomps/attachments/86.pdf (last accessed February 13, 2019).

29.

United States Department of Labor. Drug-free workplace act of. 1988. Available at https://webapps.dol.gov/elaws/asp/drugfree/screenr.htm (last accessed February 13, 2019).

30.

Stith

, Vigil

. Federal barriers to cannabis research. Science. 2016; 352:118–2.

31.

Vergara

, Bidwell

, Gaudino

, et al. Compromised external validity: federally produced cannabis does not reflect legal markets. Sci Rep. 2017; 7:4652–8.

32.

Drug Enforcement

Administration

, Department of

Justice

. Applications to become registered under the Controlled Substances Act to manufacture marijuana to supply researchers in the United States. Policy statement. Fed Regist. 2016; 81:53846–53848.

33.

The National Academy of Sciences, Engineering and Medicine. The Health effects of cannabis and cannabinoids. The National Academy Press: Washington, DC, 2017, p. 381.

34.

Nutt

, King

, Nichols

. Effects of schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci. 2013; 14:577–585.

35.

NIH Research on Marijuana and Cannabinoids. 2018. Available at https://www.drugabuse.gov/drugs-abuse/marijuana/nih-research-marijuana-cannabinoids (last accessed February 13, 2019).

36.

National Institute on Drug Abuse. About NIDA. Available at https://www.drugabuse.gov/about-nida (last accessed February 13, 2019).

37.

National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. The National Academies Press: Washington, DC, 2017.

38.

Cannabinoid-related funding opportunities from NCCIH. 2018. Available at https://nccih.nih.gov/grants/cannabinoid-research-funding-opportunities (last accessed February 13, 2019).

39.

Center for Medicinal Cannabis Research. News & information. 2019. Available at https://www.cmcr.ucsd.edu (last accessed February 13, 2019).

40.

Senate Bill 14-155. Available at https://www.colorado.gov/pacific/sites/default/files/SB155%20FINAL_2.pdf (last accessed February 13, 2019).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.07 MB